(Q33774814)

29 July 2017

1 reference

title

Chronic verrucous varicella zoster virus skin lesions: clinical, histological, molecular and therapeutic aspects (English)

1 reference

29 July 2017

Nikkels AF

1

1 reference

29 July 2017

Snoeck R

series ordinal

2

1 reference

29 July 2017

Rentier B

series ordinal

3

1 reference

29 July 2017

Pierard GE

series ordinal

4

1 reference

29 July 2017

publication date

1 September 1999

1 reference

Clinical and Experimental Dermatology

29 July 2017

published in

1 reference

29 July 2017

volume

24

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

346-353

1 reference

Varicella in patients infected with the human immunodeficiency virus

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Disseminated herpes zoster in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Herpes zoster in patients with human immunodeficiency virus infection--an ever-expanding spectrum of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Localization of varicella-zoster virus nucleic acids and proteins in human skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Chronic varicella zoster infection mimicking a basal cell carcinoma in an AIDS patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Prolonged Herpes-Zoster Infection Associated with Immunosuppressive Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Prolonged cutaneous herpes zoster in acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Atypical varicella zoster infection in persons with HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Vidarabine therapy for severe herpesvirus infections. An unusual syndrome of chronic varicella and transient immunologic deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

NIH conference. Herpes zoster-varicella infections in immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Recognition and treatment of shingles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Herpesvirus infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Herpes virus infections in immunocompromised patients: problems and therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Chronic varicella-zoster virus myelitis without cutaneous eruption in a patient with AIDS: report of a fatal case

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

21 January 2018

Chronic ocular zoster

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Chronic varicella-zoster virus skin lesions in patients with human immunodeficiency virus are related to decreased expression of gE and gB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Varicella-zoster virus latency in the adult rat is a useful model for human latent infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Varicella-zoster virus transcription in human trigeminal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Expression of varicella-zoster virus and herpes simplex virus in normal human trigeminal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Varicella-zoster virus induces apoptosis in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Treatment of acyclovir-unresponsive cutaneous herpes simplex virus infection with topically applied SP-303.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Herpes simplex chronic laryngitis and vocal cord lesions in a patient with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Chronic meningitis due to herpes simplex virus in an immunocompetent host

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Immunohistochemical identification of varicella-zoster virus gene 63-encoded protein (IE63) and late (gE) protein on smears and cutaneous biopsies: implications for diagnostic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Acyclovir resistant varicella zoster and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Meningoradiculoneuritis due to acyclovir-resistant varicella zoster virus in an acquired immune deficiency syndrome patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Foscarnet Therapy in Five Patients with AIDS and Acyclovir-resistant Varicella-Zoster Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Foscarnet-resistant multidermatomal zoster in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

The treatment of acyclovir-resistant herpes zoster with trifluorothymidine and interferon alfa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

Efficacy of A-73209, a potent orally active agent against VZV and HSV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00498.X

10.1046/J.1365-2230.1999.00498.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference